Epigral Ltd

In plain words

Price: 48.8% below its 52-week high of ₹1,709.

Delivery: 50.6% of traded shares were kept for delivery over the last 10 sessions, against 52.7% over the last 60.

A description of the data, not a recommendation.

9/100 · Weak over the last ~60 sessions, data 2026-10-30

• Delivery vs usual 4/30: Delivery 52.4% over the last 20 sessions vs 51.2% in the 40 before (1.02x); shares delivered per day 0.71x usual; 1 delivery-spike day (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
• Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
• Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
• Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
• Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
• Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.